SCHEMBL26601895

SCHEMBL26601895

Cc1cc(C(=O)O)c(C)c(C(C)(C)C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LCK P06239 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RXRB P28702 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ RET P07949 1/20 0.36
▸ LTK P29376 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13590587 0.80 ALDH1A1 (0.45) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL29225630 0.76 GABRP (0.43) ALDH1A1POLBMEN1KMT2ATDP1
SCHEMBL20346109 0.73 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL1945483 0.73 ALDH1A1 (0.58) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL29135752 0.73 MEN1 (0.43) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL17267968 0.73 IDO1 (0.40) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL25695984 0.71 ATM (0.40) KDM4EALDH1A1POLBMAPTMEN1
SCHEMBL20346114 0.70 GABRP (0.46) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL26601718 0.70 KMT2A (0.45) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL31211735 0.69 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback